International conference on botulinum toxin : basic science and clinical therapeuticsMovement disorders. 1995, Vol 10, Num 3, pp 361-404, issn 0885-3185Conference Proceedings

Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's diseaseSUCHOWERSKY, O; FURTADO, S; ROHS, G et al.Movement disorders. 1995, Vol 10, Num 3, pp 337-340, issn 0885-3185Conference Paper

Botulinum toxin treatmenty is not effective for epilepsy partialis continuaTARSY, D; SCHACHTER, S. C.Movement disorders. 1995, Vol 10, Num 3, pp 357-358, issn 0885-3185Conference Paper

L-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory rolesOPACKA-JUFFRY, J; BROOKS, D. J.Movement disorders. 1995, Vol 10, Num 3, pp 241-249, issn 0885-3185Conference Paper

Statistical prediction of the optimal site for thalamotomy in Parkinsonian tremorLENZ, F. A; NORMAND, S. L; LENZ, Y. E et al.Movement disorders. 1995, Vol 10, Num 3, pp 318-328, issn 0885-3185Conference Paper

n-Hexane-induced Parkinsonism : pathogenetic hypothesesPEZZOLI, G; ANTONINI, A; BARBIERI, S et al.Movement disorders. 1995, Vol 10, Num 3, pp 279-282, issn 0885-3185Conference Paper

Acte dystonic reaction to ectasyPRIORI, A; BERTOLASI, L; BERARDELLI, A et al.Movement disorders. 1995, Vol 10, Num 3, issn 0885-3185, p. 353Conference Paper

Off painful dystonia in Parkinson's disease treated with botulinum toxinPACCHETTI, C; ALBANI, G; MARTIGNONI, E et al.Movement disorders. 1995, Vol 10, Num 3, pp 333-336, issn 0885-3185Conference Paper

The anterior olfactory nucleus in Parkinson's diseasePEARCE, R. K. B; HAWKES, C. H; DANIEL, S. E et al.Movement disorders. 1995, Vol 10, Num 3, pp 283-287, issn 0885-3185Conference Paper

Antiparkinsonian therapies and brain mitochondrial complex I activityPRZEDBORSKI, S; JACKSON-LEWIS, V; FAHN, S et al.Movement disorders. 1995, Vol 10, Num 3, pp 312-317, issn 0885-3185Conference Paper

CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophyPLANTE-BORDENEUVE, V; BANDMANN, O; WENNING, G et al.Movement disorders. 1995, Vol 10, Num 3, pp 277-278, issn 0885-3185Conference Paper

L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brainCOOPER, J. M; DANIEL, S. E; MARSDEN, C. D et al.Movement disorders. 1995, Vol 10, Num 3, pp 295-297, issn 0885-3185Conference Paper

Lid opening apraxia is associated with medial frontal hypometabolismSMITH, D; ISHIKAWA, T; DHAWAN, V et al.Movement disorders. 1995, Vol 10, Num 3, pp 341-344, issn 0885-3185Conference Paper

Selegiline, fluoxetine, and depression in Parkinson's diseaseGARCIA-MONCO, J. C; PADIERNA, A; BELDARRAIN, M. G et al.Movement disorders. 1995, Vol 10, Num 3, issn 0885-3185, p. 352Conference Paper

Abnormalities of tracking behavior in Parkinson's diseaseHUFSCHMIDT, A; LÜCKING, C.-H.Movement disorders. 1995, Vol 10, Num 3, pp 267-276, issn 0885-3185Conference Paper

Diabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosisCLARK, J. D; RAJESH PAHWA; KOLLER, W. C et al.Movement disorders. 1995, Vol 10, Num 3, pp 353-355, issn 0885-3185Conference Paper

Longitudinal evolution of prefrontral leucotomy in Tourette's syndromeKULISEVSKY, J; BERTHIER, M. L; AVILA, A et al.Movement disorders. 1995, Vol 10, Num 3, pp 345-348, issn 0885-3185Conference Paper

Neuronal loss from the subthalamic nuclei in a patient with progressive choreaSINARD, J. H; HEDREEN, J. C.Movement disorders. 1995, Vol 10, Num 3, pp 305-311, issn 0885-3185Conference Paper

Does fluoxetine aggravate Parkinson's disease ? A pilot prospective studyMONTASTRUC, J.-L; FABRE, N; BLIN, O et al.Movement disorders. 1995, Vol 10, Num 3, pp 356-357, issn 0885-3185Conference Paper

Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenalalanine/carbidopa and selegilineDAVIS, T. L; ROZNOSKI, M; BURNS, R. S et al.Movement disorders. 1995, Vol 10, Num 3, pp 349-351, issn 0885-3185Conference Paper

Does levodopa therapy delay death in Parkinson's disease ? A review of the evidenceCLARKE, C. E.Movement disorders. 1995, Vol 10, Num 3, pp 250-256, issn 0885-3185Conference Paper

Case 1, 1995 : psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunctionSHULMAN, L. M; LANG, A. E; JANKOVIC, J et al.Movement disorders. 1995, Vol 10, Num 3, pp 257-262, issn 0885-3185Conference Paper

Pure striatonigral degeneration and Parkinson's disease : a comparative clinical studyGOUIDER-KHOUJA, N; VIDAILHET, M; BONNET, A.-M et al.Movement disorders. 1995, Vol 10, Num 3, pp 288-294, issn 0885-3185Conference Paper

Teaching tape for the motor section of the unified Parkinson's disease rating scaleGOETZ, C. G; STEBBINS, G. T; CHMURA, T. A et al.Movement disorders. 1995, Vol 10, Num 3, pp 263-266, issn 0885-3185Conference Paper

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion : preliminary findingsMARICLE, R. A; NUTT, J. G; CARTER, J. H et al.Movement disorders. 1995, Vol 10, Num 3, pp 329-332, issn 0885-3185Conference Paper